This inventor holds 1 USPTO granted patent. Top assignees: Bayer Healthcare LLC, Crispr Therapeutics Ag. Active years: 2023.
Company Filing History:
1 out of 788 
1 out of 86 
Years Active: 2023
Title: Sabine Jach: Innovator in Genome Editing
Introduction
Sabine Jach is a prominent inventor based in Leverkusen, Germany. She has made significant contributions to the field of genome editing, particularly through her innovative work on RNA-programmable endonuclease systems. Her research focuses on novel systems for targeting, editing, or manipulating DNA within cells.
Latest Patents
Sabine Jach holds 1 patent for her invention titled "RNA-programmable endonuclease systems and their use in genome editing and other applications." This patent encompasses systems that include one or more heterologous vectors encoding a SluCas9 nuclease or its variants, along with one or more guide RNAs (gRNAs). These advancements are crucial for enhancing the precision of genetic modifications.
Career Highlights
Throughout her career, Sabine has worked with notable organizations such as Bayer Healthcare LLC and Crispr Therapeutics AG. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Wayne Coco and Moritz Schmidt. Their collaborative efforts have further propelled advancements in genome editing technologies.
Conclusion
Sabine Jach's innovative work in RNA-programmable endonuclease systems positions her as a key figure in the realm of genetic research. Her contributions continue to influence the future of genome editing and its applications.